FDA orphan drug designation: treatment of malignant glioma
All entries for: EydisBio Inc.
July 11, 2025
EydisBio Inc.
Orphan Drug Designation
Baton Rogue, LA
1-50 employees
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of malignant glioma